School: aaaom.edu

Tuesday, January 7, 2014

Can Acupuncture Control Cancer Cell Growth?


Can Acupuncture Control Cancer Cell Growth?

 
On December 2, 2013, University of Minnesota professor Dr. Alvin J. Beitz presented his newly published research “The effect of electroacupuncture on osteosarcoma tumor growth and metastasis: analysis of different treatment regimens” to the students and faculty of American Academy of Acupuncture and Oriental Medicine in Roseville. Dr. Beitz also presented some basic neuroscience on acupuncture and acupuncture analgesia.

 
Osteosarcoma is the most common malignant bone tumor found in children and adolescents, and is associated with many cancer-related complications including pain and metastasis. Cancer patients have found that complementary and alternative medicine approaches can successfully address cancer pain, fatigue, and the side effects of chemotherapy. However, little is known about the effect of acupuncture treatment on cancer itself, in terms of tumor growth and metastasis.

 
Dr. Alvin Beitz is the Department Chair of the University of Minnesota’s Veterinary and Biomedical Science and professor of anatomy and neuroscience. Recently, his laboratory conducted a study which evaluated the effects of six different electroacupuncture (EA) regimens on osteosarcoma tumor growth and metastasis in both male and female mice. The most significant positive effects were observed when EA was applied to the ST-36 acupoint twice weekly (EA-2X/3) beginning at postimplantation day 3 (PID 3), which produced robust reductions in tumor growth. Conversely, when EA was applied twice weekly (EA-2X/7), starting at PID 7, there was a significant increase in tumor growth. EA-2X/3 treatment also produced a marked reduction in pulmonary metastasis, thus providing evidence for EA’s potential anti-metastatic capabilities. Dr. Beitz’s research interest also includes mechanisms underlying acupuncture’s anti-inflammatory and antinociceptive effects.
 
To read Dr. Beitz's paper, click the following link:

No comments:

Post a Comment